Astec LifeSciences Limited

NSEI:ASTEC Rapport sur les actions

Capitalisation boursière : ₹20.7b

Astec LifeSciences Croissance future

Future contrôle des critères 5/6

Astec LifeSciences devrait augmenter ses bénéfices et son chiffre d'affaires de 100.8% et de 32.9% par an respectivement. Le BPA devrait croître de de 100.9% par an. Le rendement des capitaux propres devrait être 18.2% dans 3 ans.

Informations clés

100.8%

Taux de croissance des bénéfices

100.9%

Taux de croissance du BPA

Chemicals croissance des bénéfices22.8%
Taux de croissance des recettes32.9%
Rendement futur des capitaux propres18.2%
Couverture par les analystes

Low

Dernière mise à jour04 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Jul 23
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher

Jul 03
Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher

Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Mar 15
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

May 17
Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

Oct 14
Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Jul 27
We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

Jun 28
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Jun 03
A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

May 08
Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 06
Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 25
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

Dec 13
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Jul 21
We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

May 02
Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Apr 17
The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Apr 02
Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Mar 05
Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

Feb 20
Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Feb 08
A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

Jan 28
Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Jan 17
What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 08
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Dec 28
I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Dec 18
Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Dec 07
Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Prévisions de croissance des bénéfices et des revenus

NSEI:ASTEC - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/20279,5759332529642
3/31/20267,8576361627732
3/31/20256,242-711-1361,1831
9/30/20243,729-1,036-422119N/A
6/30/20243,852-785N/AN/AN/A
3/31/20244,586-469-1,253102N/A
12/31/20234,317-509N/AN/AN/A
9/30/20234,981-258-1,580101N/A
6/30/20235,87160N/AN/AN/A
3/31/20236,285256-426747N/A
12/31/20227,735736N/AN/AN/A
9/30/20228,297975-448351N/A
6/30/20227,325883N/AN/AN/A
3/31/20226,769899-804236N/A
12/31/20215,803708N/AN/AN/A
9/30/20215,230531-800483N/A
6/30/20215,754619N/AN/AN/A
3/31/20215,587650-1,107-82N/A
12/31/20205,698723N/AN/AN/A
9/30/20205,7867741,1901,885N/A
6/30/20205,639648N/AN/AN/A
3/31/20205,2874751,2311,684N/A
12/31/20194,844291N/AN/AN/A
9/30/20194,781269-42032N/A
6/30/20194,507331N/AN/AN/A
3/31/20194,382357-375153N/A
12/31/20184,246402N/AN/AN/A
9/30/20183,781374N/AN/AN/A
6/30/20183,611325N/AN/AN/A
3/31/20183,676349N/A647N/A
12/31/20173,254212N/AN/AN/A
9/30/20173,119148N/AN/AN/A
6/30/20173,008192N/AN/AN/A
3/31/20172,987191N/A192N/A
12/31/20163,167-29N/AN/AN/A
9/30/20162,865-114N/AN/AN/A
6/30/20162,643-206N/AN/AN/A
3/31/20162,33050N/A-125N/A
12/31/20152,629-115N/AN/AN/A
9/30/20152,77761N/AN/AN/A
6/30/20152,72884N/AN/AN/A
3/31/20152,669148N/A75N/A
12/31/20142,212131N/AN/AN/A
9/30/20142,147127N/AN/AN/A
6/30/20142,15696N/AN/AN/A
3/31/20142,07087N/A146N/A
12/31/20132,17997N/AN/AN/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: ASTEC devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 6.7% ).

Bénéfices vs marché: ASTEC devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: ASTEC devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de ASTEC ( 32.9% par an) devrait croître plus rapidement que le marché Indian ( 10.6% par an).

Croissance élevée des revenus: Le chiffre d'affaires de ASTEC ( 32.9% par an) devrait croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de ASTEC devrait être faible dans 3 ans ( 18.2 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y